MD
Montosh Dey
About Montosh Dey
Data last updated:
Montosh Dey is a Director at Santexo Pharma Private Limited (since 2022), Director at Snehmedha Properties Private Limited (since 2013) and Director at Sanatra Pharma Private Limited (since 2013). The companies operate in Machinery and Equipment, Real Estate and Construction and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹14.95 Cr; the largest is Santexo Pharma Private Limited at ₹14.95 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Santexo Pharma Private Limited U85100DL2022PTC398010 | Director | 09 May 2022 | 2022 | ₹14.95 Cr (FY 2025) | Active |
| Snehmedha Properties Private Limited U70102WB2013PTC191678 | Director | 01 Apr 2013 | 2013 | ₹25,000 (FY 2022) | Active |
| Sanatra Pharma Private Limited U74900WB2013PTC191679 | Director | 02 Apr 2013 | 2013 | ₹22,500 (FY 2022) | Active |
Board colleagues of Montosh Dey
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sontosh Dey | 06461157 | Santexo Pharma Private Limited , Snehmedha Properties Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Montosh Dey
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Montosh Dey
Montosh Dey currently holds 3 directorships: Santexo Pharma Private Limited (Director, since 09 May 2022, revenue ₹14.95 Cr (FY 2025)); Snehmedha Properties Private Limited (Director, since 01 Apr 2013, revenue ₹25,000 (FY 2022)); Sanatra Pharma Private Limited (Director, since 02 Apr 2013, revenue ₹22,500 (FY 2022)).
Montosh Dey was first appointed on 01 Apr 2013 as Director at Snehmedha Properties Private Limited. The most recent appointment on record is 09 May 2022 at Santexo Pharma Private Limited.
The 3 current companies of Montosh Dey that report revenue have a combined latest revenue of ₹14.95 Cr: Santexo Pharma Private Limited ₹14.95 Cr (FY 2025); Snehmedha Properties Private Limited ₹25,000 (FY 2022); Sanatra Pharma Private Limited ₹22,500 (FY 2022).
The current boards of Montosh Dey's companies include Sontosh Dey (Santexo Pharma Private Limited).